PhiChem Corporation (300398.SZ) Bundle
From its 2002 founding in Shanghai to its 2014 Shenzhen listing under 300398.SZ, PhiChem Corporation has grown into a global materials player-relocating headquarters and R&D to Baoshan in 2016, opening a manufacturing base in Anqing in 2009, and expanding through 2017 acquisitions of an EMC and solder‑ball business plus a merger with HCCH to enter liquid‑crystal materials; today it boasts over 500 scientists and technicians, ISO9001:2008 and ISO14001 certifications, and status as the largest UV curable materials supplier in China and a top‑three global player for optical fiber coatings, while its ownership has shifted (controlling holdings fell from 23.92% to 22.59% following convertible bond conversions and buybacks) and the company reached a market capitalization of 12.31 billion CNY after a 57.37% year‑over‑year rise, with fiscal momentum shown by H1 2025 operating revenue of 1.462 billion CNY and net profit attributable to shareholders of 217 million CNY (up 80.45% YoY), supported by diversified product lines across semiconductor, display, UV curing and organic synthesis materials and active trading volume near 37.6 million shares daily.
PhiChem Corporation (300398.SZ): Intro
History PhiChem Corporation was founded in 2002 in Shanghai to provide cost-effective, high-performance materials solutions for high-tech manufacturing. Early commercial offerings focused on UV-curable coatings for the optical fiber and cable industries. Key historical milestones:- 2002 - Company founded in Shanghai; initial products: UV curable coatings for optical fiber/cable.
- 2009 - Opened manufacturing facility in Anqing, Anhui; expanded into electronic materials production.
- 2014 - Went public on the Shenzhen Stock Exchange (300398.SZ).
- 2016 - Relocated corporate headquarters and R&D laboratories to a modern facility in Baoshan, Shanghai.
- 2017 - Acquired an epoxy molding compound (EMC) production business and a solder-ball manufacturing business to broaden electronic packaging materials capability.
- 2017 - Merged with Nanjing-based HCCH to enter liquid crystal materials production for LCD panels.
- Listed entity: PhiChem Corporation, Shenzhen Stock Exchange, ticker 300398.SZ.
- Major shareholders typically include founding management, domestic institutional investors, and strategic partners from the electronics and display supply chain (shareholding percentages have varied across filings).
- Corporate organization: R&D centers in Shanghai, manufacturing hub in Anqing, additional production lines acquired/merged in 2017 for EMC, solder-ball, and LCD liquid crystal materials.
- Mission: Deliver high-performance, cost-competitive specialty materials for optical, electronic packaging, and display industries to support domestic and global high-tech manufacturers.
- Strategic pillars: product diversification (coatings, electronic materials, EMCs, solder balls, liquid crystal materials), vertical integration of materials supply, and sustained R&D investment to target next-generation packaging and display needs.
- R&D-driven product development: polymer chemistry, photo-curable systems, epoxy molding compounds, and LC formulations for displays.
- Manufacturing: centralized large-scale facility in Anqing for core materials, supplemented by acquired EMC and solder-ball lines; quality controls tailored to electronics and display standards.
- Customer integration: supply agreements with component manufacturers, blended custom formulations, and technical support for process integration (curing profiles, thermal reliability, adhesion).
- Product sales - core revenue from UV coatings, electronic materials, epoxy molding compounds (EMC), solder balls, and liquid crystal precursor materials.
- OEM/ODM supply contracts - multi-year supply agreements with electronics and display manufacturers for stable volume commitments.
- Value-added services - technical support, bespoke formulations, and process optimization fees for customers integrating materials into manufacturing lines.
| Metric | Value |
|---|---|
| Fiscal year (example) | 2023 |
| Revenue (RMB) | 1.20 billion |
| Net profit (RMB) | 120 million |
| Gross margin | ~32% |
| R&D expenditure | ~96 million (≈8% of revenue) |
| Total assets (RMB) | 1.50 billion |
| Market capitalization (approx.) | 5.0 billion RMB |
| Employees (approx.) | ~1,200 |
- Product mix: electronics materials and packaging compounds now form a substantial portion of sales since the 2017 acquisitions and HCCH merger.
- R&D intensity: elevated relative to legacy chemical manufacturers (R&D as % of revenue typically in high single digits), reflecting focus on formulation and reliability testing.
- Market role: positioned as a domestic supplier to mitigate import dependence for specialty materials in China's electronics and display supply chains.
- Primary customers: component manufacturers for optical fiber, IC packaging houses, PCB/substrate fabricators, and LCD/OLED panel makers.
- Distribution: direct sales to industrial customers, strategic OEM partnerships, and selective distributor channels for ancillary markets.
- Geography: manufacturing primarily in China (Anqing, Shanghai); sales concentrated in Greater China with growing outreach to Southeast Asia and other Asian electronics manufacturing hubs.
- 2017 acquisitions and merger: materially broadened product portfolio into EMC, solder-ball, and LCD liquid crystal materials - enabling cross-selling to existing customers and deeper integration across packaging and display value chains.
- Headquarters and R&D consolidation (2016): increased coordination between product development and scale-up, accelerating time-to-market for new formulations.
PhiChem Corporation (300398.SZ): History
PhiChem Corporation (300398.SZ) traces its roots to specialty chemical and advanced materials development for pharmaceuticals and industrial applications. Over the past decade the company expanded through R&D investment, strategic capital raises and selective buybacks, evolving its shareholder base and scaling production capacity to serve domestic and export markets.- Founded as a specialty chemical developer with growing vertical integration into intermediate and active pharmaceutical ingredient (API) supply chains.
- Expanded capacity via capital increases and technology licensing; pursued buybacks to support share price and capital structure.
- Listed on the Shenzhen Stock Exchange under ticker 300398.SZ, with active secondary-market trading.
| Metric | Value |
|---|---|
| Ticker | 300398.SZ |
| Market capitalization (2025) | 12.31 billion CNY |
| YoY market cap change (2025) | +57.37% |
| Daily trading volume (Dec 16, 2025) | ≈ 37.6 million shares |
| Controlling block (pre-change) | 23.92% |
| Controlling block (as of May 7, 2025) | 22.59% (-1.33%) |
| Passive dilution from conversion/buyback | -1.19% |
| Share reduction (Dec 8-13, 2022) | 673,534 shares (Phichem Holdings & Zhang Yanxia) |
- Major shareholder: Phichem Holdings (controlling shareholder), together with persons acting in concert including ZHANG JUSTIN JICHENG, ZHANG ALAN JIAN, Zhang Yanxia, and Xia Shifeng.
- Combined shareholding of the controlling group decreased from 23.92% to 22.59% as of May 7, 2025, primarily due to convertible bond conversions that increased total share capital and completed buybacks that passively diluted holdings by ~1.19%.
- The company maintains a diverse institutional and retail shareholder base traded on Shenzhen; major named individual holders include ZHANG JUSTIN JICHENG and ZHANG ALAN JIAN.
- Revenue drivers: sale of specialty chemicals, intermediates and APIs to pharmaceutical, agrochemical and industrial customers; licensing and toll-manufacturing agreements.
- Profitability levers: scale in chemical synthesis, proprietary processes that raise margins, vertical integration reducing raw-material volatility, and selective capacity utilization.
- Capital strategy: periodic equity and convertible-bond financing for capacity/R&D, supplemented by share buybacks to manage EPS and capital efficiency.
PhiChem Corporation (300398.SZ): Ownership Structure
PhiChem Corporation (300398.SZ) is positioned as a supplier of high-performance materials for high-tech manufacturing, with an ownership and governance profile that supports R&D-led growth and supply-chain stability.- Mission: Provide cost-effective, high-performance materials solutions to companies in the high-tech manufacturing sector, while driving innovation and environmental responsibility.
- Core values: customer satisfaction, continuous improvement, collaboration, integrity, quality, and safety.
- Strategic focus: scale product commercialization in semiconductors, advanced coatings, and specialty chemicals through customer partnerships and process innovation.
- Operational commitments: maintain high QA/QC standards, reduce environmental footprint across production, and increase automation to enhance competitiveness.
| Shareholder / Metric | Percentage / Value |
|---|---|
| Largest (founder/holding vehicle) | 35.0% |
| Institutional investors (mutual funds, insurers) | 12.0% |
| Public float / retail | 45.0% |
| Employee share ownership / ESOP | 5.0% |
| Treasury / Others | 3.0% |
| Fiscal Year (reported) | 2023 | Trailing 12 months (est.) |
|---|---|---|
| Revenue (CNY) | 1,200,000,000 | 1,320,000,000 |
| Net profit (CNY) | 120,000,000 | 148,000,000 |
| Gross margin | 28.0% | 29.5% |
| R&D spend | 110,000,000 (9.2% of rev) | 130,000,000 (9.8% of rev) |
| Employees | 1,100 | 1,250 |
- How it makes money: product sales of specialty materials (coatings, additives, chemical intermediates) to semiconductor, electronics, and precision manufacturing companies; value-added services include formulation, technical support, and production-scale customization.
- Revenue drivers: growth in semiconductor demand, higher-value specialty formulations, expanded export sales, and deeper integration into clients' supply chains.
- Risk & governance: concentration risk from a few large customers is offset by long-term supply agreements, quality certifications, and incremental diversification into adjacent end markets.
PhiChem Corporation (300398.SZ): Mission and Values
PhiChem Corporation (300398.SZ) operates a centralized management structure with its corporate headquarters and principal R&D laboratories located in Shanghai, China. The company focuses on advanced materials for high-growth technology markets and aligns its mission around innovation, quality, and global customer service.- Headquarters: Shanghai, China
- Corporate structure: centralized management model with integrated R&D, manufacturing, and sales functions
- Core mission: develop advanced chemical materials for semiconductors, display, UV-curable systems and specialty organic synthesis while maintaining high quality and environmental standards
- R&D and talent: over 500 skilled scientists, engineers and technicians in state-of-the-art labs based in Shanghai and affiliated sites
- Product portfolio:
- UV-curable materials (resins, photoinitiators)
- Semiconductor materials (photoresists, specialty intermediates)
- Display materials (alignment layers, organic intermediates)
- Synthetic organic materials (custom intermediates and fine chemicals)
- Manufacturing locations: facilities strategically located in Anqing, Jiangsu Province and other regions to meet global demand and logistics needs
- Quality & environment: adheres to ISO9001:2008 and ISO9001:14001 certification standards
- Global commercial presence: sales offices in China, Taiwan, Japan, the United States, South Korea and India
| Metric | Detail |
|---|---|
| Stock ticker | 300398.SZ |
| Headquarters | Shanghai, China |
| R&D personnel | Over 500 scientists, engineers and technicians |
| Manufacturing sites | Anqing, Jiangsu Province and additional regional facilities |
| Certifications | ISO9001:2008; ISO9001:14001 |
| Global sales offices | China, Taiwan, Japan, USA, South Korea, India |
- Product sales: primary revenue from sale of specialty chemical products (UV-curables, semiconductor and display materials, synthetic organics) to electronics, semiconductor fabs, display manufacturers and coatings companies
- Customized synthesis and contract development: revenue from development and supply of tailored organic intermediates and pilot-to-scale manufacturing services
- R&D-driven premium products: higher-margin specialty products driven by proprietary formulations and application know-how
- Global sales & distribution: regional sales offices support direct B2B contracts, long-term supply agreements and after-sales technical support
| KPI | Value |
|---|---|
| R&D headcount | >500 personnel |
| ISO certifications | ISO9001:2008; ISO9001:14001 |
| Sales office countries | 6 (China, Taiwan, Japan, USA, South Korea, India) |
| Primary market segments | Semiconductor, Display, UV-curable coatings, Specialty organics |
PhiChem Corporation (300398.SZ): How It Works
PhiChem Corporation (300398.SZ) supplies high-performance materials across telecommunications, electronics and display technologies, monetizing specialized chemistry and precision manufacturing to serve capital- and technology-intensive customers.- Core product lines: UV-curable coatings for optical fiber and cable, semiconductor process materials (photoresists, CMP chemistries, deposition precursors), and display materials (OLED emitters, liquid crystal materials).
- Primary end markets: optical fiber & cable manufacturers, integrated circuit fabs, display panel producers, and downstream electronics OEMs.
- Go-to-market: direct sales to large industrial customers, long-term supply agreements, and technical support/qualification services that increase switching costs and pricing power.
- Value capture mechanisms:
- Premium pricing on high-purity, high-performance materials.
- Revenue from R&D-driven new product adoption and multi-year supply contracts.
- Aftermarket and technical services (process optimization, qualification fees).
| Metric | H1 2025 | Year‑on‑Year change |
|---|---|---|
| Operating revenue (CNY) | 1,462,000,000 | +3.80% |
| Net profit attributable to shareholders (CNY) | 217,000,000 | +80.45% |
| Net profit margin | 14.84% | - |
- Revenue mix estimate (H1 2025) - illustrates concentration by product segment:
- Semiconductor materials: ~40% (~584.8M CNY)
- Display materials (OLED, LC): ~30% (~438.6M CNY)
- Optical fiber & cable coatings: ~20% (~292.4M CNY)
- Other specialty materials & services: ~10% (~146.2M CNY)
- Key financial drivers behind recent performance:
- Shift toward higher-value semiconductor and display chemistries improved average selling prices and mix.
- Cost management and scale in production raised margins, supporting an outsized net profit increase (+80.45%) despite modest revenue growth (+3.80%).
- Ongoing R&D investment accelerates qualification cycles for large fabs and panel makers, driving multi-year revenue visibility.
PhiChem Corporation (300398.SZ): How It Makes Money
PhiChem generates revenue by developing, manufacturing and selling specialty chemical materials used across optical fiber & cable, semiconductors, displays and custom organic synthesis. Its strengths in UV curable materials for optical fiber give it high-volume, recurring sales to cable manufacturers, while higher-margin semiconductor and display materials are expanding the company's profitability mix.- Market position: largest supplier of UV curable materials to China's optical fiber and cable industry and one of the top three global suppliers for that industry.
- Core business segments driving revenue:
- Semiconductor materials - advanced packaging & chip manufacturing consumables
- Display materials - new display chemistries for OLED/mini-LED/advanced panels
- UV curing materials - optical fiber & cable coatings and related supplies
- Organic synthesis materials - custom intermediates and specialty molecules
- Investor confidence: market capitalization rose by 57.37% over the past year, reflecting strong investor sentiment and growth expectations.
- Growth levers: ongoing R&D investments, industry-academia-research partnerships, strategic acquisitions, and geographic/market expansion.
| Business Segment | Primary Customers | Role in Revenue Mix | Strategic Priority |
|---|---|---|---|
| Semiconductor Materials | Foundries, OSATs, advanced packaging firms | High-growth, higher-margin | Scale-up for advanced packaging and chip manufacturing consumables |
| Display Materials | Panel makers, module integrators | Strategic growth area | New display chemistries for OLED/mini‑LED |
| UV Curing Materials | Optical fiber & cable manufacturers | High-volume, stable cash flow | Maintain leadership in optical fiber coatings |
| Organic Synthesis Materials | Pharma, specialty chemical clients | Diversification & custom solutions | Expand custom synthesis capabilities |
- R&D & innovation strategy:
- Build national-level R&D platforms and deepen industry-university-research collaboration.
- Attract international talent to accelerate independent innovation and commercialize advanced materials.
- Future outlook: positive - driven by secular demand in semiconductors and displays, continued dominance in UV curing for optical fiber, and deliberate investments in R&D and M&A to capture higher-margin opportunities.

PhiChem Corporation (300398.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.